Ben Halliday
Chief Financial Officer
Replay available
Esperion Therapeutics, Inc. (ESPR) Q2 2025 Earnings Call
Esperion Therapeutics, Inc. (NASDAQ: ESPR) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jason Szymanski
Analyst, Bank of America
Joe Pankinis
Analyst, H.C. Wainwright
Sheldon Koenig
President and CEO
Serge Belanger
Analyst, Needham & Company
Alina Venezia
Head of Investor Relations
Jessica Fye
Analyst, J.P. Morgan
Lisa Schaefer
Head of Marketing, U.S.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Esperion Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.236 financial results. At this time, all participants are in a listen-only mode. 00:00:05.236 -- 00:00:08.899 Following the presentation, there will be a question and answer session. 00:00:08.899 -- 00:00:13.303 Please be advised that today's conference is being recorded. 00:00:13.303 -- 00:00:18.228 I would now like to hand the conference over to Alina Venezia, Head of Investor Relations 00:00:18.228 -- 00:00:21.491 for Experian Therapeutics. Please go ahead. 00:00:21.491 -- 00:00:26.776 Thank you, Operator. Good morning, and welcome to Experian's second quarter 2025 earnings 00:00:26.776 -- 00:00:32.247 conference call. With us on today's call, are Sheldon Koenig, President and CEO, 00:00:32.247 -- 00:00:37.393 and Ben Halliday, CFO. Other members of the executive team will be available for 00:00:37.393 -- 00:00:42.618 Q&A following our prepared remarks. We issued a press release earlier this 00:00:42.618 -- 00:00:45.681 morning detailing the content of today's call. 00:00:45.681 -- 00:00:51.027 A copy can be found on the investor page of our website together with a copy of the presentation 00:00:51.027 -- 00:00:53.310 that we will also be referencing. 00:00:53.310 -- 00:00:57.995 I want to remind callers that the information discussed on today's call is covered under 00:00:57.995 -- 00:01:02.655 the Safe Harbor provision of the Private Securities Litigation Reform Act. 00:01:02.655 -- 00:01:06.719 I caution listeners that management will be making forward-looking statements. 00:01:06.719 -- 00:01:11.424 Actual results could differ materially from those stated or implied by our forward-looking 00:01:11.424 -- 00:01:15.889 statements due to the risks and uncertainties associated with the business. 00:01:15.889 -- 00:01:19.934 These fo...